European Journal of Medicinal Chemistry
短名 | Eur. J. Med. Chem. |
Journal Impact | 5.94 |
国际分区 | CHEMISTRY, MEDICINAL(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 0223-5234, 1768-3254 |
h-index | 203 |
国内分区 | 医学(2区)医学药物化学(1区) |
Top期刊 | 是 |
《欧洲药物化学杂志》是一本全球性期刊,发表关于药物化学各个方面的研究。它为发表原创论文提供了一个媒介,也欢迎评论性的论文。典型的论文将报告化合物的有机合成、表征和药理学评价。其他感兴趣的主题是药物设计、QSAR、分子建模、药物-受体相互作用、药物代谢的分子方面、前药合成和药物靶向。该杂志希望手稿能够展示研究的合理性,提供对化合物设计或机制理解的洞察力,或阐明目标。
期刊主页投稿网址涉及主题 | 化学生物生物化学遗传学立体化学医学有机化学体外内科学物理药理学核磁共振基因酶组合化学细胞培养 |
出版信息 | 出版商: Elsevier Masson s.r.l.,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1974,原创研究文献占比: 92.61%,自引率:10.00%, Gold OA占比: 11.87% |
平均审稿周期 | 网友分享经验:平均4.3个月来源Elsevier官网:平均7.4周 |
平均录用比例 | 网友分享经验:较易来源Elsevier官网:32% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells
2024-11-1
Development of Peptoid-Based Heteroaryl-Decorated Histone Deacetylase (HDAC) Inhibitors with Dual-Stage Antiplasmodial Activity
2024-11-1
Discovery of Novel BCL6-Targeting PROTACs with Effective Antitumor Activities against DLBCL in Vitro and in Vivo
2024-11-1
Graphical abstract TOC
2024-11-1
Graphical abstract TOC
2024-11-1
GPX4 Allosteric Activators Inhibit Ferroptosis and Exert Myocardial Protection in Doxorubicin-induced Myocardial Injury Mouse Model
2024-11-1
Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma
2024-11-1
Progress in the Application of Artificial Intelligence in Molecular Generation Models based on Protein Structure
2024-11-1
Carbamoylation at C-8 position of natural 3-arylcoumarin scaffold for the discovery of novel PARP-1 inhibitors with potent anticancer activity
2024-11-1
New resorcylic acid derivatives of Lysimachia tengyuehensis against MRSA and VRE by interfering with bacterial metabolic imbalance
2024-11-1
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization
2024-11-1
Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy
2024-11-1
Extracellular Heat Shock Protein 90 Alpha (eHsp90α)’s Role in Cancer Progression and the Development of Therapeutic Strategies
2024-11-1
Discovery of novel dihydropyrrolidone-thiadiazole compound crosstalk between the YycG/F two-component regulatory pathway and cell membrane homeostasis to combat methicillin-resistant Staphylococcus aureus
2024-11-1
Novel pyridazinone derivatives bind to KSRP: synthesis, anti-tumor biological evaluations and modelling insights
2024-11-1
Macrocyclic-based strategy in drug design: From lab to the clinic
2024-11-1
Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury
2024-11-1
Discovery of AMPs from Random Peptides via Deep Learning-Based Model and Biological Activity Validation
2024-11-1
Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives
2024-11-1
Thioamides in medicinal chemistry and as small molecule therapeutic agents
2024-11-1
Inducing or enhancing protein-protein interaction to develop drugs: molecular glues with various biological activity
2024-11-1
Discovery of quaternized pyridine-thiazole-ruthenium complexes as potent anti-Staphylococcus aureus agents
2024-11-1
Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy
2024-11-1
Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria
2024-11-1
Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression
2024-11-1
Indole-Core Inhibitors of Influenza A Neuraminidase: Iterative Medicinal Chemistry and Molecular Modeling
2024-11-1
Emerging Therapeutics: The imidazo[1,2-b]pyridazine scaffold as a novel drug candidate for eumycetoma, a neglected tropical disease
2024-11-1
Editorial Board
2024-11-1
Novel EGFR Inhibitors against Resistant L858R/T790M/C797S Mutant for Intervention of Non-Small Cell Lung Cancer
2024-11-1
Discovery of Novel N2-indazole Derivatives as Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Bowel Disease
2024-11-1
Novel pleuromutilin derivatives conjugated with phenyl-sulfide and boron-containing moieties as potent antibacterial agents against antibiotic-resistant bacteria
2024-11-1
Efficient Synthesis of Novel 1,10 Phenanthroline-Substituted Imidazolium Salts: Exploring Their Anticancer Applications
2024-11-1
Synthetic Approaches and Clinical Application of Representative Small-Molecule Inhibitors of Phosphodiesterase
2024-11-1
STATs, Promising Targets for the Treatment of Autoimmune and Inflammatory Diseases
2024-11-1
From Lab to Clinic: The Discovery and Optimization Journey of PI3K Inhibitors
2024-11-1
Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
2024-10-1
Natural Products Targeting Amyloid-β Oligomer Neurotoxicity in Alzheimer's Disease
2024-10-1
Novel Neuroprotective 5,6-Dihydropyrido[2',1':2,3]imidazo[4,5-c]quinoline Derivatives Acting Through Cholinesterase Inhibition and CB2 Signaling Modulation
2024-10-1
Synthesis and Evaluation of (E)-4-Hydroxy-3-methyl-but-2-enyl Diphosphate Analogs as Competitive Partial Agonists of Butyrophilin 3A1
2024-10-1
Farnesyl Pyrophosphate Synthase Inhibitors with Antiosteoporosis Efficacy in Ovariectomized Rats: A Mixed Binding Approach Beyond Bisphosphonates
2024-10-1
Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors
2024-10-1
Synthetic Approaches and Application of Representative Clinically Approved Fluorine-Enriched Anti-Cancer Medications
2024-10-1
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer
2024-10-1
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicity
2024-10-1
Anticancer activity of new water-soluble sulfonated thiosemicarbazone copper(II) complexes targeting disulfide isomerase
2024-10-1
Development of amphipathic derivatives of thymol and carvacrol as potent broad-spectrum antibacterial agents
2024-10-1
Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca2+ mobilization
2024-10-1
Editorial Board
2024-10-1
Dehydroabietylamine-substituted trifluorobenzene sulfonamide rhodamine B hybrids as anticancer agents overcoming drug resistance
2024-10-1
Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells
2024-10-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远